Literature DB >> 18650519

Sorafenib in liver cancer--just the beginning.

Lewis R Roberts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18650519     DOI: 10.1056/NEJMe0802241

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  37 in total

Review 1.  Hepatic radiation toxicity: avoidance and amelioration.

Authors:  Chandan Guha; Brian D Kavanagh
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN.

Authors:  Shi-Yan Yan; Mei-Mei Chen; Guang-Ming Li; Yu-Qin Wang; Jian-Gao Fan
Journal:  Tumour Biol       Date:  2015-02-03

3.  Up-regulation of small nucleolar RNA 78 is correlated with aggressive phenotype and poor prognosis of hepatocellular carcinoma.

Authors:  Pei Ma; Haitao Wang; Lu Han; Wei Jing; Xin Zhou; Zhisu Liu
Journal:  Tumour Biol       Date:  2016-10-21

4.  Th17, synchronically increased with Tregs and Bregs , promoted by tumour cells via cell-contact in primary hepatic carcinoma.

Authors:  W Wang; Z Wang; Y Qin; G Tang; G Cai; Y Liu; J Zhang; P Zhang; Q Shen; L Shen; W Yu
Journal:  Clin Exp Immunol       Date:  2018-01-26       Impact factor: 4.330

5.  Small activating RNA upregulates NIS expression: promising potential for hepatocellular carcinoma endoradiotherapy.

Authors:  W Xia; D Li; G Wang; J Ni; J Zhuang; M Ha; J Wang; Y Ye
Journal:  Cancer Gene Ther       Date:  2016-09-09       Impact factor: 5.987

6.  Dieckol, isolated from Ecklonia stolonifera, induces apoptosis in human hepatocellular carcinoma Hep3B cells.

Authors:  Jin-Soo Yoon; Anandam Kasin Yadunandam; Soon-Jin Kim; Hee-Chul Woo; Hyeung-Rak Kim; Gun-Do Kim
Journal:  J Nat Med       Date:  2012-10-09       Impact factor: 2.343

7.  Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model.

Authors:  Kejin Zhou; Liem H Nguyen; Jason B Miller; Yunfeng Yan; Petra Kos; Hu Xiong; Lin Li; Jing Hao; Jonathan T Minnig; Hao Zhu; Daniel J Siegwart
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

8.  The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma.

Authors:  Lijie Yuan; Hengyu Zhao; Liqiu Zhang; Xinghan Liu
Journal:  Tumour Biol       Date:  2013-08-02

9.  Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results.

Authors:  Giuseppe Salvaggio; Alessandro Furlan; Francesco Agnello; Giuseppe Cabibbo; Daniele Marin; Lydia Giannitrapani; Chiara Genco; Massimo Midiri; Roberto Lagalla; Giuseppe Brancatelli
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

Review 10.  Sorafenib: a review of its use in advanced hepatocellular carcinoma.

Authors:  Gillian M Keating; Armando Santoro
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.